STDs Binx Health Raises $104M in Series E Round The Boston-based company said it will use the funds to ramp up manufacturing of its FDA-cleared Binx io molecular point-of-care instrument, among other things. SpeeDx Inks Distribution Deal for Infectious Disease Tests in Turkey The deal covers SpeeDx's ResistancePlus and PlexPCR product lines, which include tests for sexually transmitted infections and antibiotic resistance. Enzo Biochem Sees a Path for Growth Beyond COVID Testing Premium The company said the improvements it has made to its business during the pandemic will translate to significant increases in growth once it ends. Qiagen Moves Ahead After Thwarted Thermo Fisher Buyout With NeuMoDx as Key Growth Driver Premium Qiagen has benefited from unexpected tailwinds due to COVID-19 testing and envisions post-pandemic growth with recently acquired NeuMoDx as a key contributor. FDA Provides Second Clearance for Binx MDx Platform The FDA cleared the point-of-care Binx io platform for the detection of chlamydia and gonorrhea in male urine specimens. Mar 5, 2020 Enzo Biochem Q2 Revenues Tick Up Less Than 1 Percent Mar 4, 2020 Randox Laboratories STI Assay Gets CE Mark Feb 11, 2020 New York State Approves Enzo Biochem STI Tests on GenFlex Platform Feb 11, 2020 SpeeDx Raises Additional $15M Jan 29, 2020 Hologic Fiscal Q1 Diagnostics Revenues Rise 5 Percent Jan 13, 2020 SpeeDx, LabCorp Will Codevelop MDx Tests Nov 14, 2019 Linear Diagnostics Lands £2M Investment Oct 29, 2019 Sense Biodetection Raises £12.3M to Develop Instrument-Free MDx Tests Oct 15, 2019 Enzo Biochem Fiscal Q4 Revenues Down 8 Percent Sep 6, 2019 SpeeDx Mycoplasma Genitalium Resistance Test on Cepheid System Receives CE-IVD Aug 27, 2019 After Years of Groundwork, Rapid STI MDx Space is Inaugurated With Binx FDA Clearance Premium Aug 12, 2019 FDA Clears Binx Health Point-of-Care Testing Platform for Chlamydia, Gonorrhea Aug 5, 2019 Lucira Health Closes $15M Series B Financing Jul 18, 2019 Life Sciences, Diagnostics Drive Danaher Q2 Revenues Up 4 Percent Jul 11, 2019 Enzo Biochem Gets NY Approval for Oral, Rectal CT/NG Test; Updates Lab Business Models May 23, 2019 Roche Obtains FDA Clearance for Sexually Transmitted Disease Test May 1, 2019 uBiome Shakes Up Management; Launches Investigation Into Billing Practices May 1, 2019 Binx Health Gets CE Mark for Chlamydia, Gonorrhea Point-of-Care Test Apr 25, 2019 Abbott Positions Alinity Molecular System for Labs Moving Testing to Single Platform Premium Apr 15, 2019 Cepheid Outlines Assay Improvements, Xpert Cartridge Partnering Program at ECCMID Premium Load More Breaking News People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test Yourgene Health Awarded £232K Contract to Supply Oncology Genotyping Testing Kits to NHS Wales Qiagen to Distribute JADBio Life Science Analytics Platform BC Platforms Forms Data Management Alliance With Nonprofit CureDuchenne 23andMe Stock Soars 22 Percent on Closing of Merger With VG Acquisition Corp The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.